WHAT IS DRAXXIN INJECTABLE SOLUTION?
DRAXXIN is the first member of a new subclass of macrolide antimicrobial, called triamilides, available for commercial use. DRAXXIN was discovered and developed by Zoetis for the treatment of bovine respiratory disease (BRD) in beef cattle and swine respiratory disease (SRD) and the control of respiratory disease in cattle at high risk of developing BRD.
HOW DOES THE EFFICACY OF DRAXXIN COMPARE WITH OTHER ANTIMICROBIAL TREATMENTS?
In clinical studies, only DRAXXIN provides superior efficacy against bovine respiratory disease (BRD) 14 as compared with Baytril® (enrofloxacin) Injectable Solution, Nuflor® (florfenicol) Injectable Solution and Micotil® (tilmicosin) Injection 5-8 to reduce time spent pulling and re-treating sick cattle and improve profitability.
WHAT KIND OF CATTLE CAN BE TREATED WITH DRAXXIN?
DRAXXIN is approved for use in beef and non-lactating dairy cattle for the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni (Haemophilus somnus) and Mycoplasma bovis. DRAXXIN should not be used in female dairy cattle older than 20 months of age or in calves intended to be processed for veal.
HOW IS DRAXXIN ADMINISTERED TO CATTLE?
DRAXXIN is administered by subcutaneous injection in the neck. Any of the commonly available repeat dosing syringes can be used to administer the product. The dose rate is 1.1 ml/100 lbs. (2.5 mg/kg bodyweight). No more than 10 ml (the dose for a 900 lb. animal is 10.2 ml) should be given at a single injection site.
WHAT IS THE PRE-SLAUGHTER WITHDRAWAL PERIOD FOR CATTLE TREATED WITH DRAXXIN INJECTABLE SOLUTION?
DRAXXIN has an 18-day withdrawal period. No withdrawal time has been established for pre-ruminating calves.
WHAT SIDE EFFECTS HAVE BEEN SEEN WITH DRAXXIN?
DRAXXIN caused some transient head-shaking following treatment with the recommended dose. In one field use study two calves exhibited hypersalivation and one of these calves also experienced difficulty breathing (dyspnea), which may have been associated with pneumonia.
IS DRAXXIN LABELED FOR SPECIES OTHER THAN CATTLE?
DRAXXIN injectable Solution is indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordatella bronchiseptica, Haemophilus parasuis, Mycoplasma hyopneumoniae and for the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed.
IMPORTANT SAFETY INFORMATION
Cattle: DRAXXIN has a pre-slaughter withdrawal time of 18 days. Do not use in dairy cattle 20 months of age or older. Effects on reproductive performance, pregnancy and lactation have not been determined. For complete details, refer to the full prescribing information.
Swine: The pre-slaughter withdrawal time for DRAXXIN in swine is five days. DRAXXIN should not be used in animals known to be hypersensitive to the product.